Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Vladimir Putin
United States of America
North Atlantic Treaty Organization
COVID-19
Russia-Ukraine crisis
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Russia authorizes single-shot Sputnik Light; to be produced in India
World

Russia authorizes single-shot Sputnik Light; to be produced in India

Russia authorizes single-shot Sputnik Light; to be produced in India
Written by Siddhant Pandey
May 07, 2021, 12:45 am 3 min read
Russia authorizes single-shot Sputnik Light; to be produced in India

Health officials in Russia have authorized a single-shot COVID-19 vaccine, Sputnik Light, the developers of the shot said on Thursday. The vaccine has been developed by Russia's Health Ministry, the Gamaleya National Research Center of Epidemiology and Microbiology, and the Russian Direct Investment Fund (RDIF). India will be among the countries where this new shot will be produced in the coming months.

Vaccine
Sputnik Light has demonstrated 79.4% efficacy

The vaccine's developers said in a statement that Sputnik Light has demonstrated 79.4% efficacy, according to an analysis of data gathered 28 days after the shot was administered under Russia's mass vaccination drive between December 2020 and April 2021. The Gamaleya Center has also demonstrated during laboratory testing that Sputnik Light is effective against all new strains of the coronavirus.

Trials
No serious adverse events recorded, say developers

Phase I and II of the safety and immunogenicity study of Sputnik Light had demonstrated that it can elicit the development of antigen-specific IgG antibodies in 96.9% of individuals on the 28th day after vaccination. It elicits the development of virus-neutralizing antibodies in 91.67% of individuals on the 28th day after immunization. No serious adverse events were recorded after vaccination with Sputnik Light.

Information
0.277% infection rate recorded among vaccinated subjects

After 28 days of vaccination, an infection rate of 0.277% was recorded among vaccination subjects. The infection rate among unvaccinated adults was 1.349% among unvaccinated subjects. The interim results of Phase III trials are expected in May.

Advantage
Sputnik Light can be booster shot for other vaccines

RDIF CEO Kirill Dmitriev said, "Sputnik Light makes a greater booster shot with other vaccines. We are doing trials with AstraZeneca but it can also be used with others. It can be a booster shot to upgrade other vaccines for all mutations, subject to additional trials." The vaccine's cost will be under $10 globally. It can also be stored at temperatures of 2-8°C.

Quote
'100% protection against severe infections'

Speaking at a press conference, Dmitriev said Sputnik Light resulted in "100% protection against severe infections." "Sputnik V will be the core vaccine while Sputnik Light will be cheaper and more affordable, and ensure that more people can be vaccinated quickly. Sputnik Light will be registered in several countries by next week and we are talks with regulators in several countries," he said.

Information
Sputnik Light works well against existing mutations of virus: Dmitriev

Dmitriev further said Sputnik Light works well against all existing mutations of the coronavirus as it "includes all the mutations in its code." Sputnik Light can also be used as a booster shot for other vaccines and trials are currently underway with AstraZeneca, he said.

India
Partnerships with 10 countries including India

"We hope that the 64 countries that have registered Sputnik V (the two-dose vaccine) will also register Sputnik Light," Dmitriev said. He said they have partnerships with over 20 producers—who will make both versions of the vaccine—in 10 countries including India, South Korea, and China. Sputnik V has been granted approval for emergency use by India's drug controller.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Russia News
Vaccine
Coronavirus
Sputnik V
Related
Latest
2022 Benda BD300 cruiser goes official with sporty looks
2022 Benda BD300 cruiser goes official with sporty looks Auto
Kymco Krider 400 arrives in global markets with sporty design
Kymco Krider 400 arrives in global markets with sporty design Auto
Your guide to traveling to Spiti Valley
Your guide to traveling to Spiti Valley Lifestyle
Fourth-generation Hyundai TUCSON breaks cover in India; launch in late-2022
Fourth-generation Hyundai TUCSON breaks cover in India; launch in late-2022 Auto
IPL 2022 playoffs: All you need to know
IPL 2022 playoffs: All you need to know Sports
Russia News
Coup to overthrow Putin underway: Ukraine amid 'ill health' reports
Coup to overthrow Putin underway: Ukraine amid 'ill health' reports World
Putin 'seriously ill,' claims ex-spy; oligarch says it's blood cancer
Putin 'seriously ill,' claims ex-spy; oligarch says it's blood cancer World
Putin to undergo cancer treatment, transfer power to Patrushev: Reports
Putin to undergo cancer treatment, transfer power to Patrushev: Reports World
18 dead after 500-kg bombs hit residential buildings in Ukraine
18 dead after 500-kg bombs hit residential buildings in Ukraine World
"NATO gave green light to bombing Ukraine": President Zelensky
"NATO gave green light to bombing Ukraine": President Zelensky World
More News
Vaccine
COVID-19: India logs 2,487 fresh cases, 13 more fatalities
COVID-19: India logs 2,487 fresh cases, 13 more fatalities India
COVID-19: India logs 2,858 fresh cases, 11 more fatalities
COVID-19: India logs 2,858 fresh cases, 11 more fatalities India
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon India
India inching closer to launching its first dengue vaccine
India inching closer to launching its first dengue vaccine India
National Vaccination Day 2022: Know theme, history, significance
National Vaccination Day 2022: Know theme, history, significance Lifestyle
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
Sputnik V
COVID-19: India's single-day tally drops below 1 lakh
COVID-19: India's single-day tally drops below 1 lakh India
WHO seeks more data from Sputnik V makers for EUL
WHO seeks more data from Sputnik V makers for EUL World
India mulls mixing Covishield, Sputnik doses; no recommendation yet
India mulls mixing Covishield, Sputnik doses; no recommendation yet India
COVID-19: Serum to start producing Sputnik V vaccine from September
COVID-19: Serum to start producing Sputnik V vaccine from September India
Morepen Laboratories starts production of test batch of Sputnik V
Morepen Laboratories starts production of test batch of Sputnik V India
More News
Related
Haryana may receive 60mn Sputnik V doses from Malta-based company
Haryana may receive 60mn Sputnik V doses from Malta-based company India
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022